Importantly, since RNF34 is known to target this same region [38–40], we propose a competitive binding mechanism whereby circAASS stabilizes PPARGC1A/PGC-1α during AKI by displacing RNF34. The gene discussed is PPARGC1A; the disease is acute kidney injury.